38
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12041 |
MIM1
Inhibitor of Mcl-1 |
BCL | Apoptosis |
MIM1 (Inhibitor of Mcl-1) 是一种骨髓细胞因子 1 抑制剂。 | |||
T16156 |
MT 63-78
|
Apoptosis; AMPK; mTOR | Apoptosis; Chromatin/Epigenetic; PI3K/Akt/mTOR signaling |
MT 63-78 是一种有效的直接AMPK 激活剂,EC50为 25 μM。它诱导细胞有丝分裂阻滞和细胞凋亡,通过抑制脂肪生成和mTORC1途径来阻止前列腺癌的生长,具有抗肿瘤作用。 | |||
T40230 |
Mcl-1 inhibitor 6
|
||
Mcl-1 inhibitor 6 is a potent, orally active chemical compound that selectively inhibits the myeloid cell leukemia 1 (Mcl-1) protein, with a high affinity (K d = 0.23 nM) and binding activity (K i = 0.02 μM). This compound exhibits exceptional selectivity over other members of the Bcl-2 family, including Bcl-2, Bcl2A1, Bcl-xL, and Bcl-w (K d >10 μM). Notably, Mcl-1 inhibitor 6 demonstrates strong antitumor activity. | |||
T72610 | Mcl-1 inhibitor 9 | ||
Mcl-1 inhibitor9 (example 2) 是一种 myeloid cell leukemia 1(Mcl-1) 抑制剂,IC50值为 0.21889 nM,其具有抗肿瘤活性。 | |||
T75143 | Mcl-1 inhibitor 12 | ||
Mcl-1 inhibitor12 (Example 10) 作为一种高效的MCL-1抑制剂 (Ki: 0.22 nM),主要应用于癌症研究领域。 | |||
T79036 | Mcl-1 inhibitor 13 | ||
Mcl-1 inhibitor13 (Example 9),一种MCL-1抑制剂(Ki: 8.2 nM),主要用于癌症相关研究。 | |||
T79215 |
Mcl-1 inhibitor 14
|
||
Mcl-1 inhibitor14 (Compound (Ra)-10)作为一种优异的髓系细胞白血病-1 (MCL-1) 抑制剂,其Ki值为0.018 nM,主要应用于抗癌研究领域。 | |||
T79216 |
Mcl-1 inhibitor 15
|
||
Mcl-1 inhibitor15 (Compound (Ra)-15),作为一种高效的Mcl-1抑制剂(Ki: 0.02 nM),主要应用于癌症的研究领域。 | |||
T79242 |
Mcl-1 inhibitor 16
|
||
Mcl-1 inhibitor16 (Compound 9)为基于铂的线粒体靶向性Mcl-1抑制剂。该化合物通过诱导Bax/Bak依赖的细胞凋亡(apoptosis),展现出对癌细胞的作用,可以单独使用或与ABT-199联合应用,表现出抗肿瘤活性。 | |||
T5108 |
ML311
|
BCL | Apoptosis |
ML311 是 Mcl-1/Bim 相互作用的一种选择性抑制剂。 | |||
T6034 |
UMI-77
UMI77,UMI 77 |
BCL | Apoptosis |
UMI-77是一种选择性的Mcl-1抑制剂,结合到Mcl-1的 BH3 结合沟,Ki 值为 490 nM,对 Bcl-2 家族的其他成员具有选择性。 | |||
T17247 |
VU0661013
VU661013 |
BCL | Apoptosis |
VU0661013 是一种有效的选择性 MCL-1 抑制剂。 | |||
T10096L |
Voruciclib
|
CDK | Cell Cycle/Checkpoint |
Voruciclib 是一种具有口服活性和选择性 CDK 抑制剂,Ki 为 0.626 nM-9.1 nM。它在多种弥漫性大 B 细胞淋巴瘤模型中抑制 MCL-1 的表达。它有效阻断 MCL-1 的转录调节子 CDK9。 | |||
T6650 |
Sabutoclax
BI-97C1 |
BCL | Apoptosis |
Sabutoclax (BI-97C1) 是一种泛 Bcl-2 抑制剂,包括 Bcl-xL、Bcl-2、Mcl-1 和 Bfl-1,IC50 分别为 0.31 μM、0.32 μM、0.20 μM 和 0.62 μM。 | |||
T11944 |
Maritoclax
Marinopyrrole A |
BCL | Apoptosis |
Maritoclax (Marinopyrrole A) 是一种新型特异性 Mcl-1 抑制剂,IC50值为 10.1 μM,对 BCL-xl 的 IC50值 > 80 μM。 | |||
T14834 |
BT2
3,6-二氯-2-苯并噻吩羧酸 |
BCL | Apoptosis |
BT2 是 BCKDC 激酶(BDK)抑制剂,IC50值为 3.19 μM。它也是一种选择性的Mcl-1抑制剂,Ki 值为 59 μM。BT2 与 BDK 结合触发 N 端结构域的螺旋运动,导致 BDK 从支链 α-酮酸脱氢酶复合物 (BCKDC) 中解离。 | |||
T8969 |
API-1
NSC177223 |
Akt | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
API-1 (NSC-177223) 是Akt/PKB 抑制剂,可同 PH 结构域相结合并抑制 Akt 膜易位,有效降低 Akt 的磷酸化水平。它可选择性的抑制PKB,对 PKC 和 PKA 的激活无抑制作用。它可以和 TNF 相关的凋亡诱导配体协同作用从而诱导细胞凋亡。 | |||
T9014 |
SKI-178
|
Apoptosis; S1P Receptor | Apoptosis; GPCR/G Protein |
SKI-178 是一种鞘氨醇激酶-1(SphK1)和 SphK2抑制剂,以 CDK1 依赖性方式诱导人急性髓性白血病细胞凋亡。 | |||
T12575 |
Unesbulin
PTC596 |
Apoptosis; BMI-1 | Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair |
Unesbulin (PTC596) 是一种口服有效和选择性的 B 细胞特异性莫洛尼氏鼠白血病病毒整合位点 1 抑制剂。它在急性髓细胞白血病细胞中可下调 MCL-1 并诱导不依赖 p53 的线粒体凋亡,具有抗白血病作用。 | |||
T6776 |
BAY 61-3606 dihydrochloride
BAY 61-3606,BAY-61-3606 dihydrochloride |
Apoptosis; Syk | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
BAY 61-3606 dihydrochloride (BAY 61-3606) 是一种口服有效的,ATP 竞争性的,可逆的选择性Syk 抑制剂。它降低神经母细胞瘤细胞中的 ERK1/2 和 Akt 磷酸化,也降低 K-rn 细胞裂解物中 Syk 磷酸化。它作用于乳腺癌细胞,通过下调 Mcl-1 促进 TRAIL 诱导的细胞凋亡。 | |||
T4263 |
BAY 61-3606
2-[[7-(3,4-二甲氧基苯基)咪唑并[1,2-C]嘧啶-5-基]氨基]-3-吡啶甲酰胺,Syk inhibitor IV |
Apoptosis; Syk | Angiogenesis; Apoptosis; Tyrosine Kinase/Adaptors |
BAY 61-3606 (Syk inhibitor IV) 是一种具有口服活性的,ATP 竞争性的可逆选择性Syk 抑制剂。它作用于乳腺癌细胞,通过下调 Mcl-1 促进 TRAIL 诱导的细胞凋亡。它降低神经母细胞瘤细胞中的 ERK1/2 和 Akt 磷酸化,也降低 K-rn 细胞裂解物中 Syk 磷酸化。 | |||
T11975 |
PROTAC Mcl1 degrader-1
|
BCL | Apoptosis |
PROTAC Mcl1 degrader-1 induces the ubiquitination and proteasomal degradation of Mcl-1 by introducing the E3 ligase cereblon (CRBN)-binding ligand pomalidomide to Mcl-1 inhibitor S1-6 with μM-range affinity. PROTAC Mcl1 degrader-1, a proteolysis targeting chimera (PROTAC), is a potently and selectively Mcl-1 inhibitor with an IC50 of 0.78 μM. | |||
T62249 | Bcl-2/Mcl-1-IN-1 | ||
Bcl-2/Mcl-1-IN-1 是一种 Bcl-2 (Ki: 4.53 μM) 和 Mcl-1 (Ki: 1.19 μM) 抑制剂。Bcl-2/Mcl-1-IN-1 能够用于研究癌症。 | |||
T27996 |
MDK-3298
Mcl-1 Inhibitor-5,Mcl-1 Inhibitor 5,MDK3298,Mcl-1 Inhibitor5 |
||
MDK-3298 is a reversible covalent inhibitor of Mcl-1, a target of protein-protein interaction (PPI). | |||
T16694 |
Pyridoclax
MR-29072 |
BCL | Apoptosis |
Pyridoclax is an inhibitor of potential Mcl-1. | |||
T11970 |
MCL-1/BCL-2-IN-3
|
Others | Others |
MCL-1/BCL-2-IN-3 is a selective and potent Mcl-1 and Bcl-2 dual inhibitor with IC50s of 5.95 and 4.78 μM, respectiely. | |||
T11973 | Mcl1-IN-11 | BCL | Apoptosis |
Mcl1-IN-11 (Compound G) is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.06 and 4.2 μM, respectively. | |||
T73831 |
M24
|
||
M24 是一种Mcl-1选择性抑制剂。M24 对Mcl-1表现出良好的结合亲和力,Ki 值为 0.33 μM。M24 具有良好的抗增殖活性并诱导 HepG2 细胞凋亡。 | |||
T11977 | Mcl1-IN-9 | BCL | Apoptosis |
Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM. | |||
T11974 | Mcl1-IN-12 | BCL | Apoptosis |
Mcl1-IN-12 has anti-tumor activity.It is a selective Mcl-1 inhibitor, less potent at Bcl-2, with Kis of 0.29 and 3.1 μM, respectively. | |||
T12629 |
(R)-MIK665
|
Others | Others |
(R)-MIK665 is the less active enantiomer of MIK665. MIK665 is a special inhibitor of Mcl-1(IC50 of 1.81 nM). | |||
T11968 | MCL-1/BCL-2-IN-1 | BCL | Apoptosis |
MCL-1/BCL-2-IN-2 (Compound Nap-1) 是一种有效的选择性 Mcl-1和 Bcl-2双重抑制剂,IC50分别为 4.45 和 3.18 μM。 | |||
T10846 |
CMLD010509
SDS-1-021 |
Others | Others |
CMLD010509 (SDS-1-021) is a highly selective inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MDM2, CCND1, MYC, MAF, and MCL-1. | |||
T68398 |
MI-223
|
||
MI-223 is an inhibitor of Mcl-1-stimulated homologous recombination (HR) DNA repair, which leads to sensitization of cancer cells to hydroxyurea- or olaparib-induced DNA replication stress. | |||
T79354 |
CDK9-IN-24
|
CDK | Cell Cycle/Checkpoint |
CDK9-IN-24(化合物21a)为高选择性CDK9抑制剂,显著抑止肿瘤生长。该化合物有效抑制细胞增殖,通过降调Mcl-1及c-Myc诱导细胞凋亡,适用于急性髓系白血病研究。 | |||
T21786 |
Apogossypolone (ApoG2)
|
||
Apogossypolone (ApoG2) 是一种具有口服活性的Bcl-2 家族蛋白抑制剂,对 Bcl-2, Mcl-1 和 Bcl-XL 的Ki 值分别为 35, 25 和 660 nM。Apogossypolone 具有抗肿瘤活性,可诱导细胞凋亡 (apoptosis) 和 自噬 (autophagy)。Apogossypolone 具有抗真菌活性。 | |||
T70988 |
Ibulocydine
|
||
Ibulocydine is a potent CDK inhibitor. Ibulocydine has high activity against Cdk7/cyclin H/Mat1 and Cdk9/cyclin T. Ibulocydine inhibited the growth of HCC cells more effectively than other Cdk inhibitors, including olomoucine and roscovitine, whereas ibulocydine as well as the other Cdk inhibitors and BMK-Y101 minimally influenced the growth of normal hepatocyte cells. Ibulocydine induced apoptosis in HCC cells, most likely by inhibiting Cdk7 and Cdk9. In vitro treatment of HCC cells with ibuloc... | |||
T70779 | BPR1J-340 | ||
BPR1J-340 is a potent and selective FLT3 inhibitor with potential anticancer activity. BPR1J-340 was identified as a novel potent FLT3 inhibitor by biochemical kinase activity (IC50 approximately 25 nM) and cellular proliferation (GC50 approximately 5 nM) assays. BPR1J-340 inhibited the phosphorylation of FLT3 and STAT5 and triggered apoptosis in FLT3-ITD(+) AML cells. The pharmacokinetic parameters of BPR1J-340 in rats were determined. BPR1J-340 also demonstrated pronounced tumor growth inhibit... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T30969 |
Clitocine
|
Apoptosis; BCL | Apoptosis |
Clitocine 是一种来从蘑菇中提取的一种腺苷类似物,是一种有效的转录通读剂,是一种无义突变的抑制剂,具有抗癌活性,可诱导携带 p53 无义突变等位基因的细胞产生 p53 蛋白。Clitocine 通过促进 Mcl-1 降解来增强 TRAIL 介导的人结肠癌细胞凋亡。 | |||
T3824 |
Jaceosidin
|
Apoptosis; BCL; COX; UGT | Apoptosis; Immunology/Inflammation; Metabolism; Neuroscience |
Jaceosidin 是从毛莲蒿中得到的一种黄酮类天然产物,可激活Bax,下调 Mcl-1 和 c-FLIP 的表达,诱导癌细胞凋亡。它能够降低炎性因子水平,激活 NF-κB,抑制COX-2的表达,具有抗癌和抗炎作用。 |